1. Scrip

India’s API Build-Up Plan To Bridle The Dragon

 
• By Anju Ghangurde

An Indian expert committee has recommended a raft of measures to revive and promote the production of active pharmaceutical ingredients (APIs) in the country, including the "judicious and liberal" use of anti-dumping duties and safeguards, with an eye on the country's huge reliance on Chinese imports.

While no direct reference is made to China in the recommendations of an Indian panel on the API industry, local firms have long emphasized the potentially crippling effect excessive dependence on China could have on India's own essential drugs supplies, should there be any turbulence in Indo-China relations.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from India

More from Focus On Asia